Press Centre

Welcome to Grünenthal's Press Centre

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation. Grünenthal sustainably invests in re-search and development. These investments amounted to 26 % of revenues in 2012.

You’d like to know more about Grünenthal?

In this section you will find both current and archived press releases as well as background information and a selection of images. All of these are downloadable.

If you have any further questions, please do not hesitate to contact us.